Surgical Methods for Vulvar Dysplasia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores two surgical methods to treat high-grade vulvar dysplasia, a condition with abnormal cells on the vulva. The researchers aim to determine if "Frozen-Section Directed Excision," a method used in skin surgery, is more effective than the current standard, "Wide Local Excision." Participants will be randomly assigned to one of these treatments to evaluate which offers better outcomes. This trial may suit individuals diagnosed with high-grade vulvar dysplasia and scheduled for surgery soon. As an unphased trial, it offers participants the chance to contribute to medical research that could enhance surgical outcomes for future patients.
Will I have to stop taking my current medications?
The trial requires that you have not taken immunosuppressant medications (like those for HIV, organ transplants, or chronic steroid use) in the last 30 days. If you're on these, you may need to stop before joining.
What prior data suggests that these surgical methods are safe for treating vulvar dysplasia?
Research has shown that Frozen-Section Directed Excision (FSDE) is a dependable surgical method, particularly in skin-related procedures, for accurately identifying the edges of abnormal tissue. One study found FSDE to be nearly perfect in confirming the complete removal of abnormal tissue, with an accuracy rate of 98.6%. This precision helps avoid unnecessary removal of healthy skin.
Wide Local Excision is a well-known method for treating vulvar dysplasia, involving the removal of a larger area around the abnormal tissue to ensure complete excision. This technique is usually recommended when cancer is not suspected.
Both methods are surgical procedures with some differences. FSDE, though newer for this application, shows promise in reducing residual abnormal tissue. Wide Local Excision has been used longer and is safe for non-cancerous lesions. Both methods are considered safe, but FSDE might offer more precise removal of affected tissue.12345Why are researchers excited about this trial?
Researchers are excited about exploring different surgical methods for vulvar dysplasia, focusing on Frozen-Section Directed Excision and Wide Local Excision. Unlike standard treatments that often rely on visual identification and excision with broader margins, Frozen-Section Directed Excision offers a more precise approach by allowing surgeons to make smaller, 1 mm excisions around the lesion site. This could potentially lead to better outcomes by reducing the removal of healthy tissue and preserving more of the surrounding area. By comparing this method to the traditional Wide Local Excision, which uses 5 mm margins, the trial aims to find out whether more targeted excision can provide similar or better results with less impact on the patient's quality of life.
What evidence suggests that this trial's surgical methods could be effective for vulvar dysplasia?
Research has shown that Frozen-Section Directed Excision, one of the surgical methods studied in this trial, is a promising approach for treating severe vulvar dysplasia. This technique resembles Mohs Surgery, which is effective in skin treatments. Studies have demonstrated its high accuracy, with a 98.6% success rate in identifying the edges of the affected area, allowing precise removal of diseased tissue while preserving healthy tissue.
In contrast, Wide Local Excision, another method under study, is a well-known approach for this condition. It involves removing a larger area around the abnormal tissue to ensure all unhealthy cells are taken out. This method is often recommended when there is a risk of the disease spreading, as it provides effective treatment with lower chances of recurrence. Both methods are being studied for their effectiveness in managing vulvar dysplasia, offering options based on the specific needs of each case.12345Who Is on the Research Team?
Robert W Naumann, MD
Principal Investigator
Wake Forest University Health Sciences
Are You a Good Fit for This Trial?
This trial is for adults over 18 with high-grade vulvar dysplasia who can consent, read English/Spanish, and likely have surgery within 90 days. It's not for those who've had pelvic radiation, are on immunosuppressants, or currently receiving cancer treatment.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either Frozen-Section Directed Excision or Wide Local Excision surgery
Recovery and Initial Follow-up
Participants are monitored for recovery, pain management, and initial wound healing
Follow-up
Participants are monitored for recurrence rates, quality of life, and sexual function
What Are the Treatments Tested in This Trial?
Interventions
- Frozen-Section Directed Excision
- Wide Local Excision
Frozen-Section Directed Excision is already approved in United States, European Union, Canada for the following indications:
- Basal Cell Carcinoma
- Squamous Cell Carcinoma
- Melanoma
- Vulvar Dysplasia
- Basal Cell Carcinoma
- Squamous Cell Carcinoma
- Melanoma
- Basal Cell Carcinoma
- Squamous Cell Carcinoma
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
Atrium Health Levine Cancer Institute
Collaborator